Baird cuts Iovance Biotherapeutics' target price to $9 from $11
IOVA•Baird cut its target price for Iovance Biotherapeutics to $9 from $11.
Related News
Nasdaq trade halt: volatility trading pause at 11:29 am
PARA•
JLL arranges sale of 629,018-square-foot Amazon-leased facility in Virginia
JLL•
Thursday data accumulation: GDP, PCE and jobless claims
SPY•
Megan Holdings closes US$7.5 million follow-on public offering
MGN•
Nasdaq halts trading in FVNNU for volatility at 11:39 a.m.
FVN•